 | William Clark, MD
Vice President, Clinical Strategy and Therapy Development
Gambro Renal Products, Intensive Care
Clinical Assistant Professor of Medicine
Indiana University School of Medicine
Indianapolis, IN USA Dr. Clark has been active in the field of renal replacement therapy (RRT) for several years. His specific areas of interest are solute removal and membranes in both acute kidney disease (AKI) and end-stage renal disease. Within AKI, he has numerous publications addressing the issue of RRT dose provided by different modalities, especially CRRT. |
